Total Payments
$238.10
2022 Payments
$14.22
Companies
4
Transactions
17
Medicare Patients
11,620
Medicare Billing
$786,216
Payment Breakdown by Category
Food & Beverage$238.10 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $238.10 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $116.19 | 12 | $0 (2017) |
| Novo Nordisk Inc | $96.62 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $14.22 | 1 | $0 (2022) |
| Amgen Inc. | $11.07 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $14.22 | 1 | Novartis Pharmaceuticals Corporation ($14.22) |
| 2019 | $11.07 | 1 | Amgen Inc. ($11.07) |
| 2018 | $11.71 | 1 | Novo Nordisk Inc ($11.71) |
| 2017 | $201.10 | 14 | Merck Sharp & Dohme Corporation ($116.19) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/13/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/25/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Neuroscience | ||||||
| 04/19/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Diabetes | ||||||
| 12/07/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/30/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Diabetes | ||||||
| 11/16/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/19/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/07/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/24/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/29/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ZOSTAVAX | Food and Beverage | In-kind items and services | $1.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/15/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/18/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/06/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/27/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $68.09 | General |
| Category: Diabetes | ||||||
| 02/02/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/19/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/17/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, JANUMET XR | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,045 | 3,837 | $529,978 | $148,241 |
| 2022 | 26 | 2,674 | 3,441 | $471,649 | $142,233 |
| 2021 | 26 | 3,246 | 4,313 | $677,924 | $275,650 |
| 2020 | 28 | 2,655 | 3,397 | $537,042 | $220,092 |
Total Patients
11,620
Total Services
14,988
Medicare Billing
$786,216
Procedure Codes
110
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 131 | 141 | $104,072 | $18,502 | 17.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 177 | 197 | $77,327 | $17,252 | 22.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 140 | 247 | $65,650 | $14,942 | 22.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 88 | 290 | $24,940 | $14,003 | 56.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 321 | 321 | $47,187 | $13,361 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 259 | 280 | $30,800 | $11,296 | 36.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 42 | 42 | $9,940 | $9,741 | 98.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 79 | 84 | $9,912 | $7,575 | 76.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 386 | 508 | $39,116 | $7,431 | 19.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 645 | 911 | $16,398 | $5,213 | 31.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 78 | 78 | $5,070 | $4,969 | 98.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 52 | $19,746 | $4,856 | 24.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 26 | $21,112 | $4,292 | 20.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 91 | 91 | $2,821 | $2,672 | 94.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 35 | 42 | $10,794 | $2,417 | 22.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 17 | 17 | $3,009 | $2,082 | 69.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $1,708 | $1,268 | 74.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 41 | 41 | $1,271 | $1,204 | 94.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 344 | 344 | $29,240 | $1,139 | 3.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 18 | $3,366 | $1,125 | 33.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 20 | 20 | $3,340 | $888.33 | 26.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 16 | 17 | $765.00 | $689.35 | 90.1% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 13 | 19 | $730.14 | $542.20 | 74.3% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 13 | 13 | $416.00 | $407.68 | 98.0% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 23 | 24 | $1,248 | $374.40 | 30.0% |
About Dr. Christopher Sears, MD
Dr. Christopher Sears, MD is a Internal Medicine healthcare provider based in Tiffin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427095926.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Sears, MD has received a total of $238.10 in payments from pharmaceutical and medical device companies, with $14.22 received in 2022. These payments were reported across 17 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($238.10).
As a Medicare-enrolled provider, Sears has provided services to 11,620 Medicare beneficiaries, totaling 14,988 services with total Medicare billing of $786,216. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tiffin, OH
- Active Since 06/01/2006
- Last Updated 04/24/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427095926
Products in Payments
- JANUVIA (Drug) $116.19
- Tresiba (Drug) $68.09
- Victoza (Drug) $16.82
- ENTRESTO (Drug) $14.22
- Ozempic (Drug) $11.71
- Aimovig (Biological) $11.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tiffin
Zachary West, Do, DO
Internal Medicine — Payments: $1,146
Internal Medicine $1,146
Dr. Mark Akers, M.d, M.D
Internal Medicine — Payments: $645.56
Internal Medicine $645.56
Dr. Krishnaiah Garlapati, M.d, M.D
Internal Medicine — Payments: $491.70
Internal Medicine $491.70
Dr. Mahamuni Ganesan, M.d.,, M.D.,
Internal Medicine
Internal Medicine